Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation

BACKGROUND: Long-term outcomes of lung transplantation are severely affected by comorbidities and development of chronic rejection. Among the comorbidities, kidney insufficiency is one of the most frequent and it is mainly caused by the cumulative effect of calcineurin inhibitors (CNIs). Currently,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Trials
Autori principali: Benazzo, Alberto, Cho, Ara, Nechay, Anna, Schwarz, Stefan, Frommlet, Florian, Wekerle, Thomas, Hoetzenecker, Konrad, Jaksch, Peter
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Study Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783986/
https://ncbi.nlm.nih.gov/pubmed/33397442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04843-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi